Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for Theriva Biologics Inc have a median target of 100.00, with a high estimate of 175.00 and a low estimate of 25.00. The median estimate represents a 2,531.58% increase from the last price of 3.80.
High | 4,505.3% | 175.00 |
Med | 2,531.6% | 100.00 |
Low | 557.9% | 25.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 11, 2024.
Average growth rate | -16.60% |
Average growth rate | +36.07% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
More ▼